Bicycle therapeutics reports fourth quarter and full year 2020 financial results and provides corporate update

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today reported financial results for the fourth quarter and full year ended december 31, 2020 and discussed recent corporate updates. “bicycle has overcome the unprecedented challenges caused by the covid-19 pandemic this past year, executing on our 2020 goals, inc
BCYC Ratings Summary
BCYC Quant Ranking